U
Advanced BioMedical Technologies, Inc.
ABMT
$0.0002
-$0.0004-66.67%
D
Sell
7/15/2022Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D- from E+ on 7/15/2022 due to an increase in the total return index and volatility index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D- from E+ on 7/15/2022 due to an increase in the total return index and volatility index.
E
Sell
6/30/2022Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to E+ from D- on 6/30/2022 due to a decline in the volatility index, total return index and valuation index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to E+ from D- on 6/30/2022 due to a decline in the volatility index, total return index and valuation index.
D
Sell
6/10/2022Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D- from E+ on 6/10/2022 due to an increase in the total return index and volatility index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D- from E+ on 6/10/2022 due to an increase in the total return index and volatility index.
E
Sell
5/26/2022Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to E+ from D- on 5/26/2022 due to a decline in the total return index and volatility index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to E+ from D- on 5/26/2022 due to a decline in the total return index and volatility index.
D
Sell
5/5/2022Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D- from E+ on 5/5/2022 due to an increase in the total return index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D- from E+ on 5/5/2022 due to an increase in the total return index.
E
Sell
4/20/2022Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index.
D
Sell
11/23/2021Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D- from E+ on 11/23/2021.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D- from E+ on 11/23/2021.
E
Sell
11/8/2021Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to E+ from D- on 11/8/2021 due to a decline in the total return index, solvency index and volatility index. The quick ratio declined from 0.01 to 0.01, and debt to equity increased from -0.79 to -0.78.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to E+ from D- on 11/8/2021 due to a decline in the total return index, solvency index and volatility index. The quick ratio declined from 0.01 to 0.01, and debt to equity increased from -0.79 to -0.78.
D
Sell
5/10/2021Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D- from D on 5/10/2021 due to a large decline in the growth index, total return index and volatility index. Operating cash flow declined 168.44% from $752.2 to -$514.8, and total revenue declined 24.24% from $62.3 to $47.2.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D- from D on 5/10/2021 due to a large decline in the growth index, total return index and volatility index. Operating cash flow declined 168.44% from $752.2 to -$514.8, and total revenue declined 24.24% from $62.3 to $47.2.
D
Sell
9/22/2020Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D from D- on 9/22/2020 due to a significant increase in the growth index, volatility index and valuation index. Total revenue increased 600% from -$200 to $1, operating cash flow increased 165.42% from -$155 to $101.4, and earnings per share increased from -$0.003 to -$0.0029.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D from D- on 9/22/2020 due to a significant increase in the growth index, volatility index and valuation index. Total revenue increased 600% from -$200 to $1, operating cash flow increased 165.42% from -$155 to $101.4, and earnings per share increased from -$0.003 to -$0.0029.
D
Sell
8/26/2020Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D- from D on 8/26/2020 due to a large decline in the total return index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D- from D on 8/26/2020 due to a large decline in the total return index.
D
Sell
8/11/2020Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D from D- on 8/11/2020 due to a large increase in the total return index, volatility index and valuation index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D from D- on 8/11/2020 due to a large increase in the total return index, volatility index and valuation index.
D
Sell
7/27/2020Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D- from D on 7/27/2020 due to a substantial decline in the total return index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D- from D on 7/27/2020 due to a substantial decline in the total return index.
D
Sell
7/9/2020Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D from D- on 7/9/2020 due to a large increase in the total return index and valuation index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D from D- on 7/9/2020 due to a large increase in the total return index and valuation index.
D
Sell
6/23/2020Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D- from D on 6/23/2020 due to a significant decline in the efficiency index, solvency index and growth index. Earnings per share declined from -$0.0009 to -$0.003, net income declined 228.68% from -$63.8 to -$209.7, and operating cash flow declined 198.65% from -$51.9 to -$155.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D- from D on 6/23/2020 due to a significant decline in the efficiency index, solvency index and growth index. Earnings per share declined from -$0.0009 to -$0.003, net income declined 228.68% from -$63.8 to -$209.7, and operating cash flow declined 198.65% from -$51.9 to -$155.
D
Sell
1/27/2020Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from D+ on 1/27/2020 due to a decline in the volatility index and total return index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from D+ on 1/27/2020 due to a decline in the volatility index and total return index.
D
Sell
1/10/2020Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D+ from D on 1/10/2020 due to an increase in the volatility index and growth index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D+ from D on 1/10/2020 due to an increase in the volatility index and growth index.
D
Sell
11/12/2019Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from D+ on 11/12/2019 due to a decline in the total return index and volatility index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from D+ on 11/12/2019 due to a decline in the total return index and volatility index.
D
Sell
5/7/2019Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 5/7/2019 due to a noticeable decline in the total return index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 5/7/2019 due to a noticeable decline in the total return index.
C
Hold
4/18/2019Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 4/18/2019 due to an increase in the volatility index and valuation index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 4/18/2019 due to an increase in the volatility index and valuation index.
D
Sell
4/3/2019Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D+ from D on 4/3/2019 due to a noticeable increase in the growth index and valuation index. EBIT increased 26% from -$229.6 to -$169.9, earnings per share increased from -$0.0044 to -$0.0036, and operating cash flow increased 13.39% from -$230.7 to -$199.8.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D+ from D on 4/3/2019 due to a noticeable increase in the growth index and valuation index. EBIT increased 26% from -$229.6 to -$169.9, earnings per share increased from -$0.0044 to -$0.0036, and operating cash flow increased 13.39% from -$230.7 to -$199.8.
D
Sell
3/29/2019Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from D+ on 3/29/2019 due to a decline in the volatility index and total return index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from D+ on 3/29/2019 due to a decline in the volatility index and total return index.
D
Sell
3/4/2019Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D+ from D on 3/4/2019 due to an increase in the volatility index and total return index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D+ from D on 3/4/2019 due to an increase in the volatility index and total return index.
D
Sell
2/15/2019Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from D+ on 2/15/2019 due to a decline in the volatility index, growth index and total return index. EBIT declined 68.58% from -$136.2 to -$229.6, earnings per share declined from -$0.0031 to -$0.0044, and operating cash flow declined 18.19% from -$195.2 to -$230.7.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from D+ on 2/15/2019 due to a decline in the volatility index, growth index and total return index. EBIT declined 68.58% from -$136.2 to -$229.6, earnings per share declined from -$0.0031 to -$0.0044, and operating cash flow declined 18.19% from -$195.2 to -$230.7.
D
Sell
9/20/2018Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 9/20/2018 due to a large decline in the total return index, growth index and volatility index. Operating cash flow declined 9.54% from -$178.2 to -$195.2, EBIT declined 5.91% from -$128.6 to -$136.2, and earnings per share declined from -$0.003 to -$0.0031.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 9/20/2018 due to a large decline in the total return index, growth index and volatility index. Operating cash flow declined 9.54% from -$178.2 to -$195.2, EBIT declined 5.91% from -$128.6 to -$136.2, and earnings per share declined from -$0.003 to -$0.0031.
C
Hold
8/21/2018Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to C- from C on 8/21/2018 due to a decline in the valuation index and volatility index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to C- from C on 8/21/2018 due to a decline in the valuation index and volatility index.
C
Hold
8/6/2018Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C from C- on 8/6/2018 due to an increase in the total return index, growth index and valuation index. Operating cash flow increased 21.94% from -$228.3 to -$178.2, EBIT increased 7.88% from -$139.6 to -$128.6, and earnings per share increased from -$0.0032 to -$0.003.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C from C- on 8/6/2018 due to an increase in the total return index, growth index and valuation index. Operating cash flow increased 21.94% from -$228.3 to -$178.2, EBIT increased 7.88% from -$139.6 to -$128.6, and earnings per share increased from -$0.0032 to -$0.003.
C
Hold
5/1/2018Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 5/1/2018 due to a major increase in the total return index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 5/1/2018 due to a major increase in the total return index.
D
Sell
4/16/2018Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 4/16/2018 due to a decline in the growth index, total return index and solvency index. EBIT declined 25.31% from -$111.4 to -$139.6, earnings per share declined from -$0.0027 to -$0.0032, and operating cash flow declined 0.97% from -$226.1 to -$228.3.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 4/16/2018 due to a decline in the growth index, total return index and solvency index. EBIT declined 25.31% from -$111.4 to -$139.6, earnings per share declined from -$0.0027 to -$0.0032, and operating cash flow declined 0.97% from -$226.1 to -$228.3.
C
Hold
3/1/2018Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 3/1/2018 due to an increase in the total return index, volatility index and valuation index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 3/1/2018 due to an increase in the total return index, volatility index and valuation index.
D
Sell
2/14/2018Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 2/14/2018 due to a noticeable decline in the growth index. Operating cash flow declined 60.47% from -$140.9 to -$226.1, EBIT declined 28.34% from -$86.8 to -$111.4, and earnings per share declined from -$0.0025 to -$0.0027.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 2/14/2018 due to a noticeable decline in the growth index. Operating cash flow declined 60.47% from -$140.9 to -$226.1, EBIT declined 28.34% from -$86.8 to -$111.4, and earnings per share declined from -$0.0025 to -$0.0027.
C
Hold
2/6/2018Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 2/6/2018 due to an increase in the total return index and volatility index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 2/6/2018 due to an increase in the total return index and volatility index.
D
Sell
1/18/2018Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 1/18/2018 due to a decline in the total return index, volatility index and valuation index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 1/18/2018 due to a decline in the total return index, volatility index and valuation index.
C
Hold
1/3/2018Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 1/3/2018 due to an increase in the total return index and volatility index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 1/3/2018 due to an increase in the total return index and volatility index.
D
Sell
12/19/2017Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 12/19/2017 due to a noticeable decline in the total return index and volatility index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 12/19/2017 due to a noticeable decline in the total return index and volatility index.
C
Hold
11/1/2017Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to C- from C on 11/1/2017 due to a noticeable decline in the total return index and volatility index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to C- from C on 11/1/2017 due to a noticeable decline in the total return index and volatility index.
C
Hold
10/17/2017Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C from C- on 10/17/2017 due to a large increase in the total return index, volatility index and efficiency index. Net income increased 7.26% from -$183.3 to -$170.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C from C- on 10/17/2017 due to a large increase in the total return index, volatility index and efficiency index. Net income increased 7.26% from -$183.3 to -$170.
C
Hold
7/28/2017Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 7/28/2017 due to an increase in the total return index and volatility index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 7/28/2017 due to an increase in the total return index and volatility index.
D
Sell
7/11/2017Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 7/11/2017 due to a decline in the total return index and volatility index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 7/11/2017 due to a decline in the total return index and volatility index.
C
Hold
6/26/2017Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 6/26/2017 due to a large increase in the efficiency index, total return index and growth index. Operating cash flow increased 57.37% from -$133.7 to -$57.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 6/26/2017 due to a large increase in the efficiency index, total return index and growth index. Operating cash flow increased 57.37% from -$133.7 to -$57.
D
Sell
1/13/2017Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 1/13/2017 due to a noticeable decline in the total return index and volatility index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 1/13/2017 due to a noticeable decline in the total return index and volatility index.
C
Hold
12/29/2016Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 12/29/2016 due to an increase in the growth index and volatility index. EBIT increased 27.66% from -$149.7 to -$108.3, and earnings per share increased from -$0.0032 to -$0.0026.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 12/29/2016 due to an increase in the growth index and volatility index. EBIT increased 27.66% from -$149.7 to -$108.3, and earnings per share increased from -$0.0032 to -$0.0026.
D
Sell
6/24/2016Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D+ from E+ on 6/24/2016 due to a significant increase in the efficiency index, solvency index and growth index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D+ from E+ on 6/24/2016 due to a significant increase in the efficiency index, solvency index and growth index.
E
Sell
6/21/2016Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to E+ from D on 6/21/2016 due to a significant decline in the solvency index, growth index and valuation index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to E+ from D on 6/21/2016 due to a significant decline in the solvency index, growth index and valuation index.
D
Sell
3/23/2016Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D from D- on 3/23/2016 due to a large increase in the growth index and volatility index. Earnings per share increased from -$0.0037 to -$0.0029, EBIT increased 12.97% from -$142.6 to -$124.1, and operating cash flow increased 3.75% from -$189.5 to -$182.4.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D from D- on 3/23/2016 due to a large increase in the growth index and volatility index. Earnings per share increased from -$0.0037 to -$0.0029, EBIT increased 12.97% from -$142.6 to -$124.1, and operating cash flow increased 3.75% from -$189.5 to -$182.4.
D
Sell
3/11/2016Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the volatility index, total return index and valuation index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the volatility index, total return index and valuation index.
D
Sell
2/17/2016Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from D+ on 2/17/2016 due to a large decline in the growth index and total return index. EBIT declined 1.11% from -$144.2 to -$142.6.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from D+ on 2/17/2016 due to a large decline in the growth index and total return index. EBIT declined 1.11% from -$144.2 to -$142.6.
D
Sell
10/7/2015Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 10/7/2015 due to a significant decline in the efficiency index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 10/7/2015 due to a significant decline in the efficiency index.
C
Hold
9/22/2015Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 9/22/2015 due to a significant increase in the efficiency index and total return index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 9/22/2015 due to a significant increase in the efficiency index and total return index.
D
Sell
4/8/2015Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 4/8/2015 due to a significant decline in the efficiency index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D+ from C- on 4/8/2015 due to a significant decline in the efficiency index.
C
Hold
3/24/2015Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D on 3/24/2015 due to a significant increase in the efficiency index, growth index and valuation index. Operating cash flow increased 30.38% from -$169.2 to -$220.6.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D on 3/24/2015 due to a significant increase in the efficiency index, growth index and valuation index. Operating cash flow increased 30.38% from -$169.2 to -$220.6.
D
Sell
10/3/2014Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from C- on 10/3/2014 due to a significant decline in the efficiency index and volatility index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from C- on 10/3/2014 due to a significant decline in the efficiency index and volatility index.
C
Hold
9/23/2014Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D on 9/23/2014 due to a significant increase in the efficiency index and valuation index. Net income increased 14.45% from -$184.8 to -$211.5.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D on 9/23/2014 due to a significant increase in the efficiency index and valuation index. Net income increased 14.45% from -$184.8 to -$211.5.
D
Sell
7/3/2014Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from C- on 7/3/2014 due to a significant decline in the efficiency index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from C- on 7/3/2014 due to a significant decline in the efficiency index.
C
Hold
6/24/2014Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 6/24/2014 due to a significant increase in the efficiency index and valuation index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D+ on 6/24/2014 due to a significant increase in the efficiency index and valuation index.
D
Sell
6/23/2014Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D+ from D on 6/23/2014 due to a substantial increase in the volatility index and valuation index.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to D+ from D on 6/23/2014 due to a substantial increase in the volatility index and valuation index.
D
Sell
3/28/2014Downgrade
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from C- on 3/28/2014 due to a significant decline in the efficiency index and total return index.
Advanced BioMedical Technologies, Inc. (ABMT) was downgraded to D from C- on 3/28/2014 due to a significant decline in the efficiency index and total return index.
C
Hold
3/18/2014Upgraded
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D on 3/18/2014 due to a significant increase in the efficiency index, growth index and valuation index. Operating cash flow increased 1.26% from -$166.4 to -$168.5.
Advanced BioMedical Technologies, Inc. (ABMT) was upgraded to C- from D on 3/18/2014 due to a significant increase in the efficiency index, growth index and valuation index. Operating cash flow increased 1.26% from -$166.4 to -$168.5.
OTC PK
03/31/2025 9:30AM Eastern
Quotes delayed
